Middle East & Africa Injectable Drug Delivery Market

The report "Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031", is projected to reach USD 22.54 billion by 2031 from USD 16.46 billion in 2026, at a CAGR of 6.5% during the forecast period.

Browse 280 market data Tables and 67 Figures spread through 300 Pages and in-depth TOC on "Middle East & Africa Injectable Drug Delivery Market by Product (Device, Needle-free injectors, Formulation, Solutions), Formulation Packaging (Vials, Cartridges), Therapeutic Application (Diabetes, Psoriasis), Site of Administration – Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/mea-injectable-drug-delivery-market-42151774.html

The injectable drug delivery market in the Middle East & Africa is experiencing rapid growth due to increased prevalence of chronic disease, broadening vaccination programs, and acceptance of biologics and specialty therapies. In the GCC markets, particularly in Saudi Arabia and the UAE, there has been a growing interest in self-administration and patient-centric therapies, which is expected to drive a rising demand for advanced injectables. Governments and healthcare providers across the region are forming partnerships with international pharmaceutical and technology companies to establish local manufacturing and sterile fill-finish capabilities, as well as to achieve greater regulatory alignment. Advancements in artificial intelligence-supported formulation development, smart injector systems, automated aseptic processing, and overall combination product innovation enable the delivery of more precise and widely accessible treatment regimens. The increasing adoption of digital health tools, remote monitoring platforms, and connected delivery systems enhances traceability, efficiency, and responsiveness across a growingly sophisticated injectable landscape in the Middle East & Africa.

By formulation packaging, the ampoules segment accounted for the largest market share in 2025.

In the injectable drug delivery market in the Middle East & Africa, the ampoules segment accounted for the largest market share in 2025. This is mainly due to ampules being the most frequently used and economical primary packaging format for sterile liquid medications, vaccines, and injectables for emergency use. Their simple design, high sterility assurance, and compatibility with a large number of formulation types make the ampoules suitable for high-volume public health programs as well as routine hospital use across the region. In markets where affordability, accessibility, and established healthcare practices influence purchasing decisions, ampoules continue to gain popularity because they are inexpensive to manufacture, easy to transport, and widely used in both government and private healthcare facilities.

By end user, the long-term care settings segment is expected to grow at the highest CAGR during the forecast period.

The long-term care segment is expected to grow at the highest CAGR during the forecast period, driven by the surge in prevalence of chronic and age-related conditions that require continuous injectable therapies, including diabetes, cardiovascular diseases, and autoimmune disorders. As governments expand elder-care services and invest in continuous care models, there has been higher mobilization of advanced injectables into long-term facilities to support routine management of complex patients. Growing paradigm shifts from hospital-based treatment to extended care, along with an ever-increasing demand for low-error, easy-to-administer delivery systems, further accelerate the use of injectables in these settings.

By region, GCC countries accounted for the largest share of the market in 2025.

GCC Countries accounted for the largest share of the injectable drug delivery market in the Middle East & Africa in 2025. GCC has the most advanced healthcare system, the highest per capita healthcare spending, and favorable government efforts to expand access to biologics, vaccines, and specialty injectable therapies. The region has been experiencing increased product approvals, investments in local production, and the adoption of novel delivery technologies. It has also seen a surge in chronic diseases, which has led to a demand for hospital-based and self-injected therapies.

Key Market Players

The prominent players in the Middle East & Africa injectable drug delivery market are BD (US), B. Braun SE (Germany), Terumo Corporation (Japan), Baxter (US), Cardinal Health (US), Sanofi (France), Novartis AG (Switzerland), Pfizer Inc. (US), GSK plc (UK), and Hikma Pharmaceuticals PLC (UK), among others.

Don’t miss out on business opportunities in Middle East & Africa Injectable Drug Delivery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/